Zobrazeno 1 - 9
of 9
pro vyhledávání: '"E. V. Leshenkova"'
Publikováno v:
Терапевтический архив, Vol 92, Iss 12, Pp 86-90 (2020)
Hereditary angioedema (HAE) with normal C1-inhibitor level is a rare potentially life-threatening disorder with autosomal dominant inheritance which was first described in 2000. Its clinical presentation is similar to HAE with C1-deficiency. The revi
Externí odkaz:
https://doaj.org/article/9b80f294b50f461db377951b19a3e67b
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 29-36 (2019)
Mild bronchial asthma (BA) occurs in 50–75% of patients with this disease. It is characterized by clinical symptoms that are controlled by low doses of inhaled glucocorticoids (IGCS) or anti-leukotriene drugs. Mild BA reduces the quality of life of
Externí odkaz:
https://doaj.org/article/b145f2fe75f94f33a829acca1ec5f081
Autor:
G. R. Sergeeva, A. V. Emelyanov, O. V. Korovina, A. A. Znakhurenko, E. V. Leshenkova, L. V. Kozyreva, N. . Asatiani
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 46-49 (2015)
The article presents the results of the authors' trial involving 119 patients (aged 22 to 82 years) with severe bronchial asthma (BA) diagnosed according to the ERS/ATS guidelines (2014). Allergic asthma was diagnosed in 77% of patients. The study fo
Externí odkaz:
https://doaj.org/article/ef967cd1bb36453b9ce375e676e2220a
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 18-23 (2014)
Sound approach to patient management is based on the evaluation of the overall clinical and functional pattern of the disease, including RF changes and other parameters. According to its concept, personalized treatment should be regarded as a specifi
Externí odkaz:
https://doaj.org/article/fa792f50260f4b89af347a2ae5e51c93
Autor:
G R Sergeeva, A V Emelyanov, O V Korovina, A A Znakhurenko, E V Leshenkova, L V Kozyreva, N Asatiani
Publikováno v:
Терапевтический архив, Vol 87, Iss 12, Pp 26-31 (2015)
Aim. To provide clinical characteristics of severe asthma (SA) patients encountered in clinical practice. Subjects and methods. A cross-sectional cohort study was performed to cover 119 outpatients aged 22—82 years. SA was diagnosed according to th
Externí odkaz:
https://doaj.org/article/99eaf2ca54f744a1a3c6d41478edd746
Publikováno v:
PULMONOLOGIYA. 30:437-445
Severe asthma is a heterogeneous disease consisting of several endotypes and phenotypes diagnosed due to different biomarkers. Frequency of different endotypes and phenotypes in real clinical practice needs further investigation.The aim of this study
Autor:
N. Z. Asatiani, A. V. Emel'yanov, E. V. Leshenkova, A. Sh. Rumyantsev, A. A. Znakhurenko, G. R. Sergeeva
Publikováno v:
Russian Pulmonology. 30:295-304
According to international guidelines in recent years, it has been proposed that bronchial asthma (BA) with fixed airflow obstructions (FAO) be identified as a separate phenotype.The aimof the study was the clinical and functional characterization an
Autor:
N. Z. Asatiani, E. V. Leshenkova, A. V. Emel'yanov, Kozyreva Lv, A. A. Znakhurenko, G. R. Sergeeva, O. V. Korovina
Publikováno v:
Терапевтический архив, Vol 87, Iss 12, Pp 26-31 (2015)
To provide clinical characteristics of severe asthma (SA) patients encountered in clinical practice.A cross-sectional cohort study was performed to cover 119 outpatients aged 22-82 years. SA was diagnosed according to the ERS/ATS criteria (2014). Spi
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (2)
A simple method of quantitative evaluation of modified human serum albumin (SA) was suggested for the use in clinical practice. It is based on the natural ability of modified SA to form complexes with endogenous urea. An SA content, which lost its se